Free Trial

Mirae Asset Global Investments Co. Ltd. Has $485,000 Holdings in Ceva, Inc. (NASDAQ:CEVA)

Ceva logo with Computer and Technology background

Mirae Asset Global Investments Co. Ltd. decreased its holdings in Ceva, Inc. (NASDAQ:CEVA - Free Report) by 44.9% during the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 18,690 shares of the semiconductor company's stock after selling 15,203 shares during the period. Mirae Asset Global Investments Co. Ltd. owned approximately 0.08% of Ceva worth $485,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of CEVA. GAMMA Investing LLC raised its stake in shares of Ceva by 44.5% during the first quarter. GAMMA Investing LLC now owns 3,437 shares of the semiconductor company's stock valued at $88,000 after purchasing an additional 1,058 shares during the period. Silverberg Bernstein Capital Management LLC boosted its holdings in Ceva by 16.9% in the first quarter. Silverberg Bernstein Capital Management LLC now owns 89,254 shares of the semiconductor company's stock worth $2,286,000 after purchasing an additional 12,900 shares during the period. Centaurus Financial Inc. boosted its holdings in shares of Ceva by 5.9% during the fourth quarter. Centaurus Financial Inc. now owns 19,158 shares of the semiconductor company's stock valued at $604,000 after acquiring an additional 1,075 shares during the period. AWM Investment Company Inc. boosted its holdings in shares of Ceva by 18.0% during the fourth quarter. AWM Investment Company Inc. now owns 600,162 shares of the semiconductor company's stock valued at $18,935,000 after acquiring an additional 91,668 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Ceva by 9.7% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 40,546 shares of the semiconductor company's stock valued at $1,279,000 after acquiring an additional 3,584 shares during the period. Hedge funds and other institutional investors own 85.37% of the company's stock.

Ceva Stock Up 2.0%

Ceva stock traded up $0.46 during midday trading on Wednesday, hitting $23.20. The company's stock had a trading volume of 305,273 shares, compared to its average volume of 239,725. The stock's 50-day moving average price is $21.41 and its 200-day moving average price is $27.10. Ceva, Inc. has a 12 month low of $16.02 and a 12 month high of $38.94. The company has a market capitalization of $554.71 million, a PE ratio of -82.85 and a beta of 1.26.

Ceva (NASDAQ:CEVA - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The semiconductor company reported $0.06 EPS for the quarter, missing the consensus estimate of $0.07 by ($0.01). The business had revenue of $24.25 million during the quarter, compared to the consensus estimate of $26.55 million. Ceva had a negative return on equity of 1.75% and a negative net margin of 6.11%. Ceva's revenue was up 9.8% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.05) earnings per share. As a group, equities analysts anticipate that Ceva, Inc. will post -0.12 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on CEVA shares. Oppenheimer cut their price objective on shares of Ceva from $40.00 to $33.00 and set an "outperform" rating on the stock in a research note on Friday, May 9th. Barclays cut their price objective on shares of Ceva from $40.00 to $30.00 and set an "overweight" rating on the stock in a research note on Thursday, May 8th. Wall Street Zen cut shares of Ceva from a "buy" rating to a "hold" rating in a research note on Tuesday, April 1st. Finally, Rosenblatt Securities restated a "buy" rating and set a $40.00 price objective on shares of Ceva in a research note on Thursday, May 8th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat.com, Ceva presently has a consensus rating of "Moderate Buy" and an average price target of $35.60.

View Our Latest Research Report on Ceva

Ceva Company Profile

(Free Report)

CEVA, Inc provides silicon and software IP solutions to semiconductor and original equipment manufacturer (OEM) companies worldwide. Its 5G mobile and infrastructure products include Ceva-XC vector digital signal processors (DSPs) for 5G handsets, 5G RAN, and general-purpose baseband processing; PentaG-RAN, an open ran platform for base station and radio; and PentaG2 - 5G NR modem platform for UE, as well as for non-handset 5G vertical markets, such as fixed wireless access, industry 4.0, robotics, and AR/VR devices.

Further Reading

Institutional Ownership by Quarter for Ceva (NASDAQ:CEVA)

Should You Invest $1,000 in Ceva Right Now?

Before you consider Ceva, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ceva wasn't on the list.

While Ceva currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines